Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety of rabeprazole in patients under multiple treatments.

Trial Profile

Safety of rabeprazole in patients under multiple treatments.

Phase of Trial: Phase IV

Latest Information Update: 18 May 2011

At a glance

  • Drugs Rabeprazole (Primary)
  • Indications Gastrointestinal disorders
  • Focus Adverse reactions
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 15 Nov 2009 Status changed from active, no longer recruiting to discontinued.
    • 14 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top